Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4543386
Max Phase: Preclinical
Molecular Formula: C30H38F5N7O7S
Molecular Weight: 621.71
Molecule Type: Unknown
Associated Items:
ID: ALA4543386
Max Phase: Preclinical
Molecular Formula: C30H38F5N7O7S
Molecular Weight: 621.71
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C)C/C=C/C(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)C3CCC(F)(F)CC3)CC2)c1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C28H37F2N7O5S.C2HF3O2/c1-36(2)14-4-7-24(38)32-21-5-3-6-22(17-21)43(41,42)37-15-10-20(11-16-37)33-27(40)25-23(18-31-35-25)34-26(39)19-8-12-28(29,30)13-9-19;3-2(4,5)1(6)7/h3-7,17-20H,8-16H2,1-2H3,(H,31,35)(H,32,38)(H,33,40)(H,34,39);(H,6,7)/b7-4+;
Standard InChI Key: NIMMYMFPIKVTJO-KQGICBIGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 621.71 | Molecular Weight (Monoisotopic): 621.2545 | AlogP: 2.81 | #Rotatable Bonds: 10 |
Polar Surface Area: 156.60 | Molecular Species: BASE | HBA: 7 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.85 | CX Basic pKa: 8.80 | CX LogP: 1.90 | CX LogD: 0.48 |
Aromatic Rings: 2 | Heavy Atoms: 43 | QED Weighted: 0.30 | Np Likeness Score: -1.71 |
1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS.. (2019) Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14., 29 (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024] |
Source(1):